Where precision
meets clinical
intelligence.

Expert review and sign-off of promotional and medical materials — ensuring scientific accuracy, balance, and full compliance with EFPIA, LIF/LER, and local codes. Thorough, documented, and defensible.

Handling unsolicited medical information requests from HCPs — providing compliant, evidence-based responses with full documentation. A critical service that pharma teams consistently need external capacity for.

Drafting, reviewing, and maintaining SOPs, governance frameworks, and compliance documentation — aligned to EFPIA, local industry codes, and company standards. Audit-ready, always.

End-to-end management of investigator-sponsored research proposals — scientific review, compliance workflow, documentation, and ongoing oversight throughout the study lifecycle.

Building scientifically accurate and engaging training content on disease areas, product data, and scientific messaging — for KAM teams, commercial colleagues, and internal stakeholders.

Supporting publication strategy, manuscript development, and author coordination — from outline to submission. Aligned to GPP guidelines and your broader medical communications strategy.

Rigorous onsite monitoring visits ensuring protocol adherence, data integrity, and site compliance — drawing on direct experience educating investigators and site staff in patient management, sampling procedures, and safety reporting across multiple therapeutic areas and European markets.

End-to-end trial management — study start-up, site coordination, timeline oversight, risk management, and regulatory submissions. Operational discipline combined with scientific depth.

Clinical study reports, regulatory dossiers, protocols, investigator brochures, publications, and medical education materials — written with scientific precision and strategic clarity.

Preparing a clinical asset to change hands — trial master file reconciliation, document inventory and gap closure, so that an acquiring party, a licensing partner or an inspector can rely on the record from day one. And medical input to the assessment of assets coming the other way.

Building the medical affairs plan at whatever level it is needed — the global plan written with regional input, and the Nordic or national plan translated from it and adapted to local clinical landscapes, healthcare systems and regulatory environments.

Identifying and mapping Key Opinion Leaders, planning non-promotional scientific exchange programmes, and building the HCP relationships that drive meaningful medical insight.

Full-service advisory board management — from KOL identification and scientific agenda design to back-office logistics, compliance sign-off, and output documentation that captures every insight.

Providing the medical and scientific narrative that supports HTA submissions, reimbursement dossiers, and payer discussions — translating clinical evidence into compelling access arguments.

Originating the research question itself — shaping a hypothesis worth testing, building the internal and clinician coalition behind it, designing the analysis, and carrying it through to peer-reviewed publication. The work that happens before there is a study to manage.